Literature DB >> 12044564

Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by hydrophilic additives.

Y Yamaguchi1, M Takenaga, A Kitagawa, Y Ogawa, Y Mizushima, R Igarashi.   

Abstract

We investigated the controlled release of human insulin at an initial stage from poly(DL-lactic-co-glycolic acid) (PLGA, M(w) 6600) spherical matrices. PLGA microcapsules were prepared by the novel solvent evaporation multiple emulsion process. When the crystalline insulin was dispersed in dichloromethane as solid-in-oil (S/O) dispersion, it was found that most of insulin molecules were inlaid on the surface of PLGA microcapsules. Consequently, insulin-loaded PLGA microcapsules exhibited marked rapid release of insulin within several hours in both in vivo and in vitro experiments. On the other hand, the addition of glycerol or water in the primary dichloromethane dispersion results in drastically suppressed initial release. It was found by SEM observation that water- or glycerol-in-oil (W/O or G/O) type mini-emulsion droplets with a mean diameter of 300-500 nm were formed in this primary solution. This phenomenon can be theoretically presumed to occur because insulin and PLGA molecules, having amphiphilic properties, converge on the interface between the hydrophilic additive and dichloromethane. Hence, insulin molecules heterogeneously located in the inside of PLGA microcapsules, not on the surface, would be gradually released with PLGA hydrolytic decomposition. As an additional effect of glycerol, the initial burst was further suppressed due to the decrease of the glass transition temperature of PLGA from 42.5 to 36.7 degrees C. Since the annealing of PLGA molecules took place at around 37 degrees C, the porous structure of microspheres immediately disappeared after immersion in PBS or subcutaneous administration. The insulin diffusion through the water-filled pores would be effectively prevented. The strict controlled initial release of insulin from the PLGA microsphere suggested the possibility of utilization in insulin therapy for type I diabetic patients who need construction of a basal insulin profile.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12044564     DOI: 10.1016/s0168-3659(02)00060-3

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  15 in total

1.  Role of particle size in phagocytosis of polymeric microspheres.

Authors:  Julie A Champion; Amanda Walker; Samir Mitragotri
Journal:  Pharm Res       Date:  2008-03-29       Impact factor: 4.200

Review 2.  Long-term delivery of protein therapeutics.

Authors:  Ravi Vaishya; Varun Khurana; Sulabh Patel; Ashim K Mitra
Journal:  Expert Opin Drug Deliv       Date:  2014-09-24       Impact factor: 6.648

3.  In Vitro-In Vivo Relationship of Amorphous Insoluble API (Progesterone) in PLGA Microspheres.

Authors:  Chenguang Pu; Qiao Wang; Hongjuan Zhang; Jingxin Gou; Yuting Guo; Xinyi Tan; Bin Xie; Na Yin; Haibing He; Yu Zhang; Yanjiao Wang; Tian Yin; Xing Tang
Journal:  Pharm Res       Date:  2017-09-25       Impact factor: 4.200

Review 4.  Biosafe nanoscale pharmaceutical adjuvant materials.

Authors:  Shubin Jin; Shengliang Li; Chongxi Wang; Juan Liu; Xiaolong Yang; Paul C Wang; Xin Zhang; Xing-Jie Liang
Journal:  J Biomed Nanotechnol       Date:  2014-09       Impact factor: 4.099

5.  Role of a novel excipient poly(ethylene glycol)-b-poly(L-histidine) in retention of physical stability of insulin at aqueous/organic interface.

Authors:  Ajay Taluja; You Han Bae
Journal:  Mol Pharm       Date:  2007-04-18       Impact factor: 4.939

6.  Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.

Authors:  Ge Jiang; Wei Qiu; Patrick P DeLuca
Journal:  Pharm Res       Date:  2003-03       Impact factor: 4.200

7.  Preparation and characteristics of DNA-nanoparticles targeting to hepatocarcinoma cells.

Authors:  Qin He; Ji Liu; Xun Sun; Zhi-Rong Zhang
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

8.  Effect of MgO nanofillers on burst release reduction from hydrogel nanocomposites.

Authors:  Hadi Hezaveh; Ida Idayu Muhamad
Journal:  J Mater Sci Mater Med       Date:  2013-03-21       Impact factor: 3.896

9.  Potential Roles of the Glass Transition Temperature of PLGA Microparticles in Drug Release Kinetics.

Authors:  Kinam Park; Andrew Otte; Farrokh Sharifi; John Garner; Sarah Skidmore; Haesun Park; Young Kuk Jhon; Bin Qin; Yan Wang
Journal:  Mol Pharm       Date:  2020-12-17       Impact factor: 5.364

10.  Encapsulation of the reductase component of p-hydroxyphenylacetate hydroxylase in poly(lactide-co-glycolide) nanoparticles by three different emulsification techniques.

Authors:  Komkrich Sawasdee; Jeerus Sucharitakul; Taweesak Dhammaraj; Nuttawee Niamsiri; Pimchai Chaiyen; Kanlaya Prapainop
Journal:  IET Nanobiotechnol       Date:  2018-06       Impact factor: 1.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.